BioSupply Trends - Marketplace News
FFF Enterprises FFF Enterprises | Home FFF Enterprises | Contact Us
July 20, 2011
FFF Enterprises | Patient Safety + Product Efficacy + Fair Pricing
 
In This Issue
  • IVIG Supply Index
  • Albumin Supply Index
  • Open Market Pricing
  • Reimbursement Rates
  • Industry News
  • Subscribe to BST Quarterly
  • Subscribe to IG Living
  • MyFluVaccine Orders
  • Resources
Subscribe to BioSupply Trends eNewsletter
  FFF Enterprises
(800) 843-7477
FFF Enterprises | Free Reference Charts for Hyperimmunes, Immune Globulins, Factor and Injectable Influenza
Hyperimmune
Immune Globulin
Factor
Injectable Influenza
Place Your Flu Vaccine Order on MyFluVaccine.com
Place Your Flu Vaccine Order on MyFluVaccine.com
Subscribe to BioSupply Trends Quarterly magazine
BioSupplyTrends Quarterly magazine, your definitive source for the biopharmaceuticals marketplace
Subscribe to IG Living! magazine
IG Living! magazine, the magazine for the immune globulin community
FFF Enterprises | Helping Healthcare Care - place an order

Flu Cases Four Times Higher Than Last Year
AUSTRALIA is in the grip of a grim flu outbreak, with the number of influenza cases four times higher than a year ago. Experts believe the rise could be linked to the sudden deluge of wet weather and floods earlier this year when there was an unusually high number of flu cases recorded.
Read the full article »

WHO Urges Europeans to Vaccinate Against Measles
The World Health Organization has warned that European cases of measles are on the rise and urged people to vaccinate themselves against the disease to prevent it from spreading. The WHO European Region says it recorded more than 12,000 cases between January and May 2011 – exceeding the total for 2010. It says the worst outbreaks were seen in France, with 7,324 cases, and in Spain, with 1,146 cases.
Read the full article »

 
 
      
 
IVIG Supply Index represents  FFF's aggregate inventory of  all IVIG products for all our  customers who have established  product allocations with us  (not individual or group  allocations).  Blue represents 21 days supply or less, purple is 22 to 29 days, green is 30 days supply or more.  Albumin Supply Index represents FFF's aggregate inventory of Albumin for all our customers who have  established product allocations  with us (not individual or group  allocations). Blue represents 21 days supply or less, purple is 22 to 29 days, green is 30 days supply or more.
 
FFF Enterprises | Open Market Pricing
 
  
 

Focus on Baxter's Tisseel
Tisseel, a two-component fibrin sealant consisting of human fibrinogen and human thrombin, is indicated for use as an adjunct to hemostasis when conventional surgical techniques are ineffective or impractical. When combined, the two components mimic the final stage of the blood coagulation cascade. For more information, contact FFF's Wow! Customer Care™ at (800) 843-7477.

Heard about Gammaplex?
Immune Globulin Intravenous (Human)
Approved for IVIG treatment of PIDD patients, Gammaplex, 5% liquid immune globulin intravenous, is made without sucrose, glucose or maltose. With low IgA, competitive infusion time and no refrigeration required, Gammaplex is a proven option for replacement therapy. Visit gammaplex.com or call (800) 843-7477 to learn more.

 
  
 
Current CMS / IVIG Rates
Product Hospital Outpatient Physician's Office
Carimune NF 61.589 62.176
Flebogamma 5% & 10% DIF 70.600* 70.600
Gammagard Liquid 75.378 76.096
Gammagard S/D 61.589 62.176
Gammaplex 75.838* 75.838
Gamunex-C 74.639 75.350
Privigen 69.445 70.106
*ASP + 6% (Medicare pass-through drug)
Rates per gram are effective July 1, 2011 through September 30, 2011
 
  
 

Industry News
From ABC 7 News
Study: No Link Between Swine Flu Shot, Guillain-Barre
more »

From PR Newswire
MedImmune Submits Supplemental Biologics License Application for Quadrivalent Seasonal Nasal Spray Influenza Vaccine
more »

From Science Daily
Research Illuminating Long-Term Non-Progression Suggests Novel Vaccination Strategy for HIV
more »

From Reuters
FDA Plans Oversight of Some Mobile Medical Apps
more »

 
 
   
   
 
FFF Enterprises | Patient Safety + Product Efficacy + Fair Pricing
Home | About Us | Contact   ©2011 FFF Enterprises, Inc.